In the US, gastric cancer is most frequently diagnosed in the advanced stage, with only approximately 5% of patients surviving beyond five years.... Jan 18
GSK plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient non-endometrial advanced solid cancers being presented today at the ... Jan 18
-Advertisements-